Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01145430
Title Veliparib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer or Metastatic Breast Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Her2-receptor negative breast cancer

peritoneal carcinoma

ovary epithelial cancer

fallopian tube carcinoma

Therapies

Pegylated liposomal-doxorubicin + Veliparib

Age Groups: adult
Covered Countries USA


No variant requirements are available.